| Product Code: ETC13176505 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Africa Vaccines Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Africa Vaccines Market Overview |
3.1 Africa Regional Macro Economic Indicators |
3.2 Africa Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Africa Vaccines Market - Industry Life Cycle |
3.4 Africa Vaccines Market - Porter's Five Forces |
3.5 Africa Vaccines Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Africa Vaccines Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 Africa Vaccines Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.8 Africa Vaccines Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.9 Africa Vaccines Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.10 Africa Vaccines Market Revenues & Volume Share, By Patient Type, 2021 & 2031F |
4 Africa Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Africa Vaccines Market Trends |
6 Africa Vaccines Market, 2021 - 2031 |
6.1 Africa Vaccines Market, Revenues & Volume, By Technology, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Africa Vaccines Market, Revenues & Volume, By Conjugate vaccines, 2021 - 2031 |
6.1.3 Africa Vaccines Market, Revenues & Volume, By Inactivated and subunit vaccines, 2021 - 2031 |
6.1.4 Africa Vaccines Market, Revenues & Volume, By Live attenuated vaccines, 2021 - 2031 |
6.1.5 Africa Vaccines Market, Revenues & Volume, By Recombinant vaccines, 2021 - 2031 |
6.1.6 Africa Vaccines Market, Revenues & Volume, By Toxoid vaccines, 2021 - 2031 |
6.2 Africa Vaccines Market, Revenues & Volume, By Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Africa Vaccines Market, Revenues & Volume, By Monovalent vaccines, 2021 - 2031 |
6.2.3 Africa Vaccines Market, Revenues & Volume, By Multivalent vaccines, 2021 - 2031 |
6.3 Africa Vaccines Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Africa Vaccines Market, Revenues & Volume, By Pneumococcal disease, 2021 - 2031 |
6.3.3 Africa Vaccines Market, Revenues & Volume, By DTP, 2021 - 2031 |
6.3.4 Africa Vaccines Market, Revenues & Volume, By Influenza, 2021 - 2031 |
6.3.5 Africa Vaccines Market, Revenues & Volume, By HPV, 2021 - 2031 |
6.3.6 Africa Vaccines Market, Revenues & Volume, By Meningococcal disease, 2021 - 2031 |
6.3.7 Africa Vaccines Market, Revenues & Volume, By Polio, 2021 - 2031 |
6.3.8 Africa Vaccines Market, Revenues & Volume, By Rotavirus, 2021 - 2031 |
6.3.9 Africa Vaccines Market, Revenues & Volume, By Other disease indications, 2021 - 2031 |
6.4 Africa Vaccines Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Africa Vaccines Market, Revenues & Volume, By Intramuscular and subcutaneous administration, 2021 - 2031 |
6.4.3 Africa Vaccines Market, Revenues & Volume, By Oral administration, 2021 - 2031 |
6.4.4 Africa Vaccines Market, Revenues & Volume, By Other routes of administration, 2021 - 2031 |
6.5 Africa Vaccines Market, Revenues & Volume, By Patient Type, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Africa Vaccines Market, Revenues & Volume, By Pediatric patients, 2021 - 2031 |
6.5.3 Africa Vaccines Market, Revenues & Volume, By Adult patients, 2021 - 2031 |
7 Africa Vaccines Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Africa Vaccines Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.2.1 South Africa Vaccines Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.2.2 Egypt Vaccines Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.2.3 Nigeria Vaccines Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.2.4 Rest of Africa Vaccines Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.3 Africa Vaccines Market Revenues & Volume Share, By Type, 2021 & 2031F |
7.3.1 South Africa Vaccines Market, Revenues & Volume, By Type, 2021 - 2031 |
7.3.2 Egypt Vaccines Market, Revenues & Volume, By Type, 2021 - 2031 |
7.3.3 Nigeria Vaccines Market, Revenues & Volume, By Type, 2021 - 2031 |
7.3.4 Rest of Africa Vaccines Market, Revenues & Volume, By Type, 2021 - 2031 |
7.4 Africa Vaccines Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.4.1 South Africa Vaccines Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.4.2 Egypt Vaccines Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.4.3 Nigeria Vaccines Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.4.4 Rest of Africa Vaccines Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.5 Africa Vaccines Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5.1 South Africa Vaccines Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5.2 Egypt Vaccines Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5.3 Nigeria Vaccines Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5.4 Rest of Africa Vaccines Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.6 Africa Vaccines Market, Revenues & Volume, By Patient Type, 2021 - 2031 |
7.6.1 South Africa Vaccines Market, Revenues & Volume, By Patient Type, 2021 - 2031 |
7.6.2 Egypt Vaccines Market, Revenues & Volume, By Patient Type, 2021 - 2031 |
7.6.3 Nigeria Vaccines Market, Revenues & Volume, By Patient Type, 2021 - 2031 |
7.6.4 Rest of Africa Vaccines Market, Revenues & Volume, By Patient Type, 2021 - 2031 |
8 Africa Vaccines Market Key Performance Indicators |
9 Africa Vaccines Market - Export/Import By Countries Assessment |
10 Africa Vaccines Market - Opportunity Assessment |
10.1 Africa Vaccines Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Africa Vaccines Market Opportunity Assessment, By Technology, 2021 & 2031F |
10.3 Africa Vaccines Market Opportunity Assessment, By Type, 2021 & 2031F |
10.4 Africa Vaccines Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
10.5 Africa Vaccines Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10.6 Africa Vaccines Market Opportunity Assessment, By Patient Type, 2021 & 2031F |
11 Africa Vaccines Market - Competitive Landscape |
11.1 Africa Vaccines Market Revenue Share, By Companies, 2022 |
11.2 Africa Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here